“Cancer Testis Antigen (CTA) T21, As a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours”. Journal of Medical Sciences, vol. 17, no. 1, Jan. 2022, pp. 1-7, https://doi.org/10.51984/joms.v17i1.1892.